Viewing Study NCT05338892


Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2025-12-26 @ 8:31 PM
Study NCT ID: NCT05338892
Status: COMPLETED
Last Update Posted: 2023-10-19
First Post: 2022-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module